EVOK Overview
Upcoming Projects (EVOK)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (EVOK)
-
What Will Phase 3 Results for EVK-001 in Acute and Recurrent Diabetic Gastroparesis in Women Mean for Evoke?
Ticker: EVOK
Execute By: Aug 31, 2016
Upcoming & Overdue Catalysts (EVOK)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (EVOK)
-
Evoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti
Ticker: EVOK
Occurred on: Sep 07, 2016 -
Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001
Ticker: EVOK
Occurred on: Jul 26, 2016 -
Evoke Pharma Announces $4.5 Million At-The-Market Offering
Ticker: EVOK
Occurred on: Jul 20, 2016 -
Evoke Phase 3 Results for EVK-001 in Acute and Recurrent Diabetic Gastroparesis in Women Expected Early Q3
Ticker: EVOK
Occurred on: Jul 18, 2016 -
Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility
Ticker: EVOK
Occurred on: Mar 01, 2016
Strategic Initiatives (EVOK)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
